The University of Chicago Header Logo

A phase II study of subcutaneous recombinant human interleukin-4 in metastatic renal cell carcinoma.

A phase II study of subcutaneous recombinant human interleukin-4 in metastatic renal cell carcinoma. Cancer. 1995 Nov 01; 76(9):1629-33.

View in: PubMed